Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

被引:62
|
作者
Mayer-Hamblett, Nicole [1 ,2 ,6 ]
Ramsey, Bonnie W. [1 ,6 ]
Kulasekara, Hemantha D. [3 ]
Wolter, Daniel J. [1 ]
Houston, Laura S. [1 ]
Pope, Christopher E. [1 ]
Kulasekara, Bridget R. [3 ]
Armbruster, Catherine R. [3 ]
Burns, Jane L. [1 ,6 ]
Retsch-Bogart, George [7 ]
Rosenfeld, Margaret [1 ,6 ]
Gibson, Ronald L. [1 ,6 ]
Miller, Samuel I. [3 ,4 ,5 ]
Khan, Umer [6 ]
Hoffman, Lucas R. [1 ,3 ,6 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98105 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA
[5] Univ Washington, Dept Med, Seattle, WA 98105 USA
[6] Seattle Childrens Hosp, Washington, DC USA
[7] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; Pseudomonas aeruginosa; phenotypic characterization; eradication; antibiotic treatment; YOUNG-CHILDREN; COLONY MORPHOLOGY; LUNG-FUNCTION; LASR MUTANTS; INFECTION; ADAPTATION; TOBRAMYCIN; DISEASE; AIRWAYS; DIVERSIFICATION;
D O I
10.1093/cid/ciu385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF). Due to its association with lung disease progression, initial detection of P. aeruginosa in CF respiratory cultures usually results in antibiotic treatment with the goal of eradication. Pseudomonas aeruginosa exhibits many different phenotypes in vitro that could serve as useful prognostic markers, but the relative relationships between these phenotypes and failure to eradicate P. aeruginosa have not been well characterized. Methods. We measured 22 easily assayed in vitro phenotypes among the baseline P. aeruginosa isolates collected from 194 participants in the 18-month EPIC clinical trial, which assessed outcomes after antibiotic eradication therapy for newly identified P. aeruginosa. We then evaluated the associations between these baseline isolate phenotypes and subsequent outcomes during the trial, including failure to eradicate after antipseudomonal therapy, emergence of mucoidy, and occurrence of an exacerbation. Results. Baseline P. aeruginosa isolates frequently exhibited phenotypes thought to represent chronic adaptation, including mucoidy. Wrinkly colony surface and irregular colony edges were both associated with increased risk of eradication failure (hazard ratios [95% confidence intervals], 1.99 [1.03-3.83] and 2.14 [1.32-3.47], respectively). Phenotypes reflecting defective quorum sensing were significantly associated with subsequent mucoidy, but no phenotype was significantly associated with subsequent exacerbations during the trial. Conclusions. Pseudomonas aeruginosa phenotypes commonly considered to reflect chronic adaptation were observed frequently among isolates at early detection. We found that 2 easily assayed colony phenotypes were associated with failure to eradicate after antipseudomonal therapy, both of which have been previously associated with altered biofilm formation and defective quorum sensing.
引用
收藏
页码:624 / 631
页数:8
相关论文
共 50 条
  • [1] Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis
    P. Vidya
    L. Smith
    T. Beaudoin
    Y. C. W. Yau
    S. Clark
    B. Coburn
    D. S. Guttman
    D. M. Hwang
    V. Waters
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 67 - 74
  • [2] Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis
    Vidya, P.
    Smith, L.
    Beaudoin, T.
    Yau, Y. C. W.
    Clark, S.
    Coburn, B.
    Guttman, D. S.
    Hwang, D. M.
    Waters, V.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (01) : 67 - 74
  • [3] Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis
    Blanchard, Ana C.
    Horton, Eric
    Stanojevic, Sanja
    Taylor, Louise
    Waters, Valerie
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 395 - 400
  • [4] Effects of a Pseudomonas aeruginosa eradication policy in a cystic fibrosis clinic
    Davidson, A. George F.
    Chilvers, Mark A.
    Lillquist, Yolanda P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (06) : 615 - 621
  • [5] Eradication of Pseudomonas aeruginosa in an adult patient with cystic fibrosis
    Hayes, Don, Jr.
    Feola, David J.
    Murphy, Brian S.
    Kuhn, Robert J.
    Davis, George A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (04) : 319 - 322
  • [6] Early Eradication of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
    Stuart, Bridget
    Lin, Jenny H.
    Mogayzel, Peter J., Jr.
    PAEDIATRIC RESPIRATORY REVIEWS, 2010, 11 (03) : 177 - 184
  • [7] The Approach to Pseudomonas aeruginosa in Cystic Fibrosis
    Bendiak, Glenda N.
    Ratjen, Felix
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (05) : 587 - 595
  • [8] Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis
    Mayer-Hamblett, Nicole
    Kronmal, Richard A.
    Gibson, Ronald L.
    Rosenfeld, Margaret
    Retsch-Bogart, George
    Treggiari, Miriam M.
    Burns, Jane L.
    Khan, Umer
    Ramsey, Bonnie W.
    PEDIATRIC PULMONOLOGY, 2012, 47 (02) : 125 - 134
  • [9] Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis
    Proesmans, M.
    Vermeulen, F.
    Boulanger, L.
    Verhaegen, J.
    De Boeck, K.
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (01) : 29 - 34
  • [10] Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis
    Stanojevic, Sanja
    Waters, Valerie
    Mathew, Joseph L.
    Taylor, Louise
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (02) : 172 - 178